These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 93703)

  • 1. Shape change of blood platelets brought about by myelin basic protein and other basic polypeptides.
    Laubscher A; Pletscher A; Honegger CG; Richards JG
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Dec; 310(1):87-92. PubMed ID: 93703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shape change of blood platelets induced by myelin basic protein.
    Laubscher A; Pletscher A; Honegger CG; Richards JG; Colombo V
    Experientia; 1979 Aug; 35(8):1081-3. PubMed ID: 89969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of myelin basic protein on the endogenous phosphorylation of platelets.
    Chiang TM; Whitaker JN; Kang AH; Beachey EH
    Thromb Res; 1982 Mar; 25(6):487-99. PubMed ID: 6180500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits.
    Gudat F; Laubscher A; Otten U; Pletscher A
    Br J Pharmacol; 1981 Nov; 74(3):533-8. PubMed ID: 6170375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets.
    Best LC; McGuire MB; Martin TJ; Preston FE; Russell RG
    Biochim Biophys Acta; 1979 Mar; 583(3):344-51. PubMed ID: 221045
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
    Bowen R; Haslam RJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Nezu A; Shinoda H; Minami M
    Br J Pharmacol; 1996 Jan; 117(2):299-304. PubMed ID: 8789382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotides in hypertension.
    Hamet P; Franks DJ; Adnot S; Coquil JF
    Adv Cyclic Nucleotide Res; 1980; 12():11-23. PubMed ID: 6250345
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood platelets as models for central 5-hydroxytryptaminergic neurons.
    Pletscher A; Laubscher A; Graf M; Saner A
    Ann Biol Clin (Paris); 1979; 37(1):35-9. PubMed ID: 443611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of basic polypeptides and proteins with calmodulin.
    Itano T; Itano R; Penniston JT
    Biochem J; 1980 Sep; 189(3):455-9. PubMed ID: 6163425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood platelets as models for neurons: uses and limitations.
    Pletscher A; Laubscher A
    J Neural Transm Suppl; 1980; (16):7-16. PubMed ID: 6933224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
    Vanderwel M; Haslam RJ
    J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin basic protein depolarizes neuronal membranes.
    Gähwiler BH; Honegger CG
    Neurosci Lett; 1979 Mar; 11(3):317-21. PubMed ID: 92776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactions of polylysine with human platelets in plasma and in suspensions of washed platelets.
    Guccione MA; Packham MA; Kinlough-Rathbone RL; Perry DW; Mustard JF
    Thromb Haemost; 1976 Nov; 36(2):360-75. PubMed ID: 827032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet.
    Terashita Z; Imura Y; Nishikawa K
    Biochem Pharmacol; 1985 May; 34(9):1491-5. PubMed ID: 2986648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.